Response to: 'Correspondence on 'Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study'' by Zheng
- PMID: 33558257
- DOI: 10.1136/annrheumdis-2021-219856
Response to: 'Correspondence on 'Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study'' by Zheng
Keywords: epidemiology; glucocorticoids; osteoporosis; rheumatoid arthritis.
Conflict of interest statement
Competing interests: JvdB reports grants from Amgen, Eli Lilly and UCB, outside the submitted work. AB received research grants to her department from Celgene and AbbVie, and speakers’ fees or honoraria from Sandoz, UCB, Lilly, Novartis and Biogen, and Gilead also to her department, not related to the current study. FdV supervises 3 PhD students who are employed with F. Hoffmann La Roche Ltd (Basel, Switzerland/Welwyn Garden City, UK). He has not received any fees or reimbursements for this, and the topics of their PhD thesis are not related to the current study proposal. SA, JD, AMB, PCS and TPvS have no competing interests.
Comment on
-
Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study.Ann Rheum Dis. 2021 Apr;80(4):423-431. doi: 10.1136/annrheumdis-2020-218758. Epub 2020 Dec 11. Ann Rheum Dis. 2021. PMID: 33310727
-
Correspondence on 'Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study'.Ann Rheum Dis. 2023 Apr;82(4):e93. doi: 10.1136/annrheumdis-2020-219797. Epub 2021 Feb 8. Ann Rheum Dis. 2023. PMID: 33558260 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical